A look at the day ahead from Julien Ponthus.
The U.N. climate summit in Glasgow is coming to an end, and so far it hasn't proved to be a game changer.
Under countries' current pledges, global warming is likely to rise well above 1.5 degrees Celsius above pre-industrial levels and unleash catastrophic sea level rising, floods and droughts.
While world leaders seem stuck behind the curve on climate change, many investors are also wondering whether the global economy isn"t sleepwalking into an era of high inflation.
The U.S Federal Reserve is still miles away from a rate increase with the U.S. inflation at its highest in three decades. The Fed is still buying billions of securities monthly, but it will soon start pasing out monetary stimulus.
In the meantime, U.S. 10 - year real rates - - the nominal rate minus headline inflation - - is nearing - 5%, a level only seasoned traders came across in the 1970 s and early 1980 s.
Some investors see cracks in the Fed's transitory inflation narrative which they are not inclined to buy into.
In Europe, a poll of economists showed that euro zone inflation expectations are at risk of getting overtaken by the European Central Bank's 2% target next year.
While the initial shock of Wednesday's U.S. inflation data seems to be falling, the dollar is currently at 16 month high and 10 year U.S. Treasuries yield is about 15 basis points higher than the 1,41% it priced two days ago.
The all- country world index of MSCI remains within a striking distance of its all-time high, hit earlier this week. European and Wall Street futures are flat and are currently pointing to a subdued session ahead.
A decision by General Electric's to split into three public companies is one of the interesting developments for stock markets, as Japan's Toshiba outlining plans to spin off two core businesses, a decision that follows a similar move by Japan's Toshiba to split into three public companies.
The key developments that should give more direction to markets on Friday: Deutsche Telekom core profit beats estimates; full-year outlook raised - AstraZeneca makes over $1 billion in Q 3 vaccine sales, small profit
JoLTS job openings due to the U.S. Uni of Michigan sentiment, conditions and inflation expectations